Psychedelic Healthcare Innovation: PsiloThera Announces Launch of Quantum Technology Drug Development Program
HENDERSON, Nev., July 30, 2021 /PRNewswire/ -- PsiloThera, Inc. is a pioneering Psychedelic Healthcare Innovation& Life Sciences Company developing Psilocybin ("Magic Mushroom") based Drugs and Therapies proudly announces the launch of its Quantum Technology Drug Development Program.
- HENDERSON, Nev., July 30, 2021 /PRNewswire/ -- PsiloThera, Inc. is a pioneering Psychedelic Healthcare Innovation& Life Sciences Company developing Psilocybin ("Magic Mushroom") based Drugs and Therapies proudly announces the launch of its Quantum Technology Drug Development Program.
- "Quantum Technology could ultimately change the way that Humans digest supplements, medications and nutrients."
- "Quantum technology may lead to advances that could ultimately change the way that Humans digest supplements, medications and nutrients."
- PsiloThera's outstanding battle tested management team will operate the Company's vertical business model which includes; Fungi Grow, Research & Development, Drug Development, Tele-Mental Health Platform and PsiloThera Treatment Centers.